INGARON(intranasal)

INGARON® (interferon gamma, 100,000 IU) recombinant human interferon-gamma (immune interferon) has immunostimulating and antiviral activity: promotes formation of cell resistance against influenza virus. INGARON® efficiently stimulates immunity and ensures protection against influenza, including H5N1and H1N1.

The drug is administered intranasally (nasal drops)

• The only interferon gamma drug in the Russian Federation
• Listed in VED list
• Listed in the Standards of Specialized Medical Aid for medium to severe influenza and severe ARVI
• Possesses a comprehensively wide spectrum of activity – it affects the majority of viral infection agents
• Intensifies the effect of many anti-viral drugs used in combined therapy of ARVI and influenza
• INGARON® does not develop resistance

Lophilizate for preparation of solution for intranasal application in vials, 100,000 IU in each vial.
Packaging set: 1 vial of drug, 1 vial of water for injection (5 ml) and 1 cap-dropper made of polyethylene in packaging of polyethylene or medical dropper in contour cellular package or in cassette contour package.

1 or 5 of contour package with application instructions are put into cardboard package.
1 or 5 vials of the drug respectively supplied with 1 or 5 cap-droppers made of polyethylene in packaging of polyethylene or medical dropper and with application instructions are put into cardboard package.

Prevention and treatment (as part of combined therapy) of influenza. Prevention and treatment (as part of combined therapy) of influenza H5N1 and H1N1.

Individual intolerance of interferon gamma or any other component of the drug. Pregnancy. Children (below 7 years old).